Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Ajai K. Chaudhary"'
Autor:
Basira G Abdul, Everett J. Perkins, Ajai K. Chaudhary, Enaksha R Wickremsinhe, Jennifer L Hanes, Kenneth J. Ruterbories, Naijia H Huang, John W Richard
Publikováno v:
Bioanalysis. 3:1635-1646
Background: The adoption of dried blood spot (DBS) sampling and analysis to support drug discovery and development requires the understanding of its bioanalytical feasibility as well as the distribution of the analyte in blood. Results: Demonstrated
Autor:
Ajai K. Chaudhary, Ragu Ramanathan
Publikováno v:
Bioanalysis. 2:1181-1184
The inaugural Applied Pharmaceutical Analysis–India (APA–India) conference was held between 21 and 24 February 2010 in Hyderabad, India. The theme of the 2010 APA–India meeting was “The best of bioanalytical science in India: the role of bioa
Autor:
Anthony J. DeStefano, Daniel Tang, Jacqueline A. O'Shaughnessy, Marian Kelley, Ajai K. Chaudhary, S. Peter King, Russell Weiner, Douglas M. Fast, C. T. Viswanathan
Publikováno v:
The AAPS Journal. 11:238-241
The Conference Report of the 3rd AAPS/FDA Bioanalytical Workshop (Crystal City III) endorsed the concept that assay methods supporting bioanalytical data in submissions must demonstrate assay reproducibility by using incurred samples. The present Wor
Publikováno v:
Annual Review of Analytical Chemistry. 1:357-396
Current drug discovery involves a highly iterative process pertaining to three core disciplines: biology, chemistry, and drug disposition. For most pharmaceutical companies the path to a drug candidate comprises similar stages: target identification,
Autor:
Chris H. Takimoto, Alain C. Mita, Andrew Goetz, Robert D. Johnson, Lorinda Simms, Sharyn D. Baker, Tuhin K. Chaudhuri, Kathleen Molpus, Lisa A. Hammond, Christopher Sweeney, Eric K. Rowinsky, Anthony W. Tolcher, Alan Sandler, Miguel A. Villalona-Calero, Jane E. Latz, Amita Patnaik, Ajai K. Chaudhary
Publikováno v:
Journal of Clinical Oncology. 24:552-562
Purpose This phase I study was conducted to determine the toxicities, pharmacokinetics, and recommended doses of pemetrexed in cancer patients with normal and impaired renal function. Patients and Methods Patients received a 10-minute infusion of 150
Autor:
Phil Marder, Linda A. Battiato, Christopher Sweeney, Ajai K. Chaudhary, Karen Fife, Christopher Jordan, Alan B. Sandler, Isabelle Pouliquen, Michael S. Gordon, Lisa J. Green, Michael Burgess, Christopher A. Slapak, Dinesh P. de Alwis
Publikováno v:
Clinical Cancer Research. 10:3265-3272
Purpose: The purpose of this study was to investigate the safety and tolerability of Zosuquidar.3HCl, a potent inhibitor of P-glycoprotein (Pgp), when administered p.o. alone and in combination with doxorubicin and to determine whether Zosuquidar.3HC
Autor:
Ajai K. Chaudhary
Publikováno v:
Bioanalysis. 1:503-505
Publikováno v:
Biomedical Chromatography. 13:455-461
A quantitative method was developed and validated for rapid and sensitive analysis of cimetidine in human plasma. The method involved the use of liquid chromatography (LC) coupled with atmospheric pressure chemical ionization (APCI) and selected reac
Autor:
M Nokubo, G R Reddy, Ian A. Blair, Lawrence J. Marnett, Carol A. Rouzer, Ajai K. Chaudhary, D M Ferguson
Publikováno v:
Chemical Research in Toxicology. 10:181-188
A method is described for the assay of the major malondialdehyde-deoxyguanosine adduct (M1G) based on immunoaffinity purification and gas chromatography/electron capture/negative chemical ionization/mass spectrometry. A stable isotope of M1G-deoxyrib
Autor:
Clark Tibbetts, Kaylon L. Bruner, Ajai K. Chaudhary, Mounir Benamira, Kristin A. Johnson, Lawrence J. Marnett
Publikováno v:
Carcinogenesis. 16:93-99
The mutagenicity of the lipid peroxidation product, malondialdehyde (MDA), was measured in the lacZ alpha forward mutation assay using a recombinant M13 phage, M13MB102. Single-stranded M13MB102 DNA was reacted with MDA at neutral pH and the modified